We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Again Delays In-Person Inspections Due to Omicron Concerns
FDA Again Delays In-Person Inspections Due to Omicron Concerns
The FDA has extended its delay on conducting in-person domestic surveillance in-spections through Feb. 4 with the goal of restarting the activities as soon as safely pos-sible.